• Please log in or register to access this feature.

Intervention Review

Oral versus intravenous steroids for treatment of relapses in multiple sclerosis

  1. Jodie M Burton1,*,
  2. Paul W O'Connor2,
  3. Marika Hohol2,
  4. Joseph Beyene3

Editorial Group: Cochrane Multiple Sclerosis and Rare Diseases of the Central Nervous System Group

Published Online: 12 DEC 2012

Assessed as up-to-date: 13 JUN 2012

DOI: 10.1002/14651858.CD006921.pub3

Database Title

Additional Information

How to Cite

Burton JM, O'Connor PW, Hohol M, Beyene J. Oral versus intravenous steroids for treatment of relapses in multiple sclerosis. Cochrane Database of Systematic Reviews 2012, Issue 12. Art. No.: CD006921. DOI: 10.1002/14651858.CD006921.pub3.

Author Information

  1. 1

    University of Calgary, Department of Clinical Neurosciences, Calgary, Alberta, Canada

  2. 2

    St. Michael's Hospital, Division of Neurology, Toronto, Ontario, Canada

  3. 3

    McMaster University, Clinical Epidemiology and Biostatistics, Hamilton, Ontario, Canada

*Jodie M Burton, Department of Clinical Neurosciences, University of Calgary, 1403 29th St NW, Calgary, Alberta, T2N 2T9, Canada. jodie.burton@albertahealthservices.ca.

Publication History

  1. Publication Status: New search for studies and content updated (no change to conclusions)
  2. Published Online: 12 DEC 2012

SEARCH

ARTICLE TOOLS

View Full Article (HTML) Summary (61K)Standard (445K)Full (649K)

  1. Current Version

    Oral versus intravenous steroids for treatment of relapses in multiple sclerosis

    Jodie M Burton, Paul W O'Connor, Marika Hohol and Joseph Beyene

    Article first published online: 12 DEC 2012 | DOI: 10.1002/14651858.CD006921.pub3

Previous versions of this article and their online publication dates

  1. Version 2

    Oral versus Intravenous Steroids for Treatment of Relapses in Multiple Sclerosis

    Jodie M Burton, Paul W O'Connor, Marika Hohol and Joseph Beyene

    Article first published online: 8 JUL 2009 | DOI: 10.1002/14651858.CD006921.pub2

  2. Version 1

    Oral versus Intravenous Steroids for Treatment of Relapses in Multiple Sclerosis

    Jodie Melissa Burton, Paul W O'Connor, Marika Hohol and Joseph Beyene

    Article first published online: 15 APR 2009 | DOI: 10.1002/14651858.CD006921

View Full Article (HTML) Summary (61K)Standard (445K)Full (649K)